Type 1 diabetes mellitus in adolescents

Adolescent Medicine: State of the Art Reviews

Volumn 21, Issue 1, 2010, Pages 86-102

  Adi, Saleh ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; INSULIN;

ADOLESCENT; DEPRESSION; EXERCISE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; PHYSIOLOGY; PSYCHOLOGICAL ASPECT; PUBERTY; REVIEW;

ADOLESCENT; DEPRESSION; DIABETES MELLITUS, TYPE 1; EXERCISE; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; PUBERTY;

EID: 77954687480     PISSN: 19344287     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (123)

1. Writing Group for the SEARCH for Diabetes in Youth Study Group, Dabelea D, Bell RA, et al. Incidence of diabetes in youth in the United States. JAMA. 2007;297:2716-2724
2. Zeitler P. Update on nonautoimmune diabetes in children. J Clin Endocrinol Metab. 2009;94:2215-2220
3. American Diabetes Association. Type 2 diabetes in children and adolescents. Diabetes Care. 2000;23:381-390
4. Matyka KA. Type 2 diabetes in childhood: epidemiological and clinical aspects. Br Med Bull. 2008;86:59-75
5. Bell RA, Mayer-Davis EJ, Beyer JW, et al. SEARCH for Diabetes in Youth Study Group. Diabetes in non-Hispanic white youth: prevalence, incidence, and clinical characteristics: the SEARCH for Diabetes in Youth Study. Diabetes Care. 2009;32(Suppl 2):S102-S111
6. Concannon P, Rich SS, Nepom GT. Genetics of type 1A diabetes. N Engl J Med. 200916;360:1646-1654
7. Wenzlau JM, Juhl K, Yu L, et al. The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetes. Proc Natl Acad Sei U S A. 2007;104:17040-17045
8. O'Neill SK; Liu E, Cambier JC. Change you can B (cell) eive in: recent progress confirms a critical role for B cells in type 1 diabetes. Curr Opin Endocrinol Diabetes Obes. 2009;16:293-298
9. DIAMOND Project Group. Incidence and trends of childhood Type 1 diabetes worldwide 1990-1999. Diabet Med. 2006;23:857-866
10. Onkamo P, Vaananen S, Karvonen M, Tuomilehto J. Worldwide increase in incidence of Type I diabetes-the analysis of the data on published incidence trends. Diabetologia. 1999;42:1395-1403
11. LéVy-Marchal C, Patterson C, Green A. Variation by age group and seasonality at diagnosis of childhood IDDM in Europe. The EURODIAB ACE Study Group. Diabetologia. 1995;38:823-380
12. Hekkala A, Knip M, Veijola R. Ketoacidosis at diagnosis of type 1 diabetes in children in northern Finland: temporal changes over 20 years. Diabetes Care. 2007;30:861-866
13. Maniatis AK, Goehrig SH, Gao D, Rewers A, Walravens P, Klingensmith GJ. Increased incidence and severity of diabetic ketoacidosis among uninsured children with newly diagnosed type 1 diabetes mellitus. Pediatr Diabetes. 2005;6:79-83
14. Neu A, Willasch A, Ehehalt S, Hub R, Ranke MB. DIARY Group Baden-Wuerttemberg. Ketoacidosis at onset of type 1 diabetes mellitus in children-frequency and clinical presentation. Pediatr Diabetes. 2003;4:77-81
15. Sundaram PC, Day E, Kirk JM. Delayed diagnosis in type 1 diabetes mellitus. Arch Dis Child. 2009;94:151-152
16. Rewers A, Klingensmith G, Davis C, et al. Presence of diabetic ketoacidosis at diagnosis of diabetes mellitus in youth: the Search for Diabetes in Youth Study. Pediatrics. 2008;121:El258-El266
17. Balasubramanyam A, Nalini R, Hampe CS, Maldonado M. Syndromes of Ketosis-Prone Diabetes Mellitus. Endocr. Rev. 2008;29:292-302
18. Umpierrez GE, Smiley D, Kitabchi AE. Narrative review: ketosis-prone type 2 diabetes mellitus. Ann Intern Med. 2006;144:350-357
19. Giuffrida FM, Reis AF. Genetic and clinical characteristics of maturity-onset diabetes of the young. Diabetes Obes Metab. 2005;7:318-326
20. Biiyiikgebiz A, Cemeroglu AP, Bober E, Mohn A, Chiarelli F. Factors influencing remission phase in children with type 1 diabetes mellitus. J Pediatr Endocrinol Metab. 2001;14:1585-1596
21. Bowden SA, Duck MM, Hoffman RP. Young children (<5 yr) and adolescents (>12 yr) with type 1 diabetes mellitus have low rate of partial remission: diabetic ketoacidosis is an important risk factor. Pediatr Diabetes. 2008;9:197-201
22. Abdul-Rasoul M, Habib H, Al-Khouly M. 'The honeymoon phase' in children with type 1 diabetes mellitus: frequency, duration, and influential factors. Pediatr Diabetes. 2006;7:101-107
23. Rabbone I, Bobbio A, Berger K, Trada M, Sacchetti C, Cerutti F. Age-related differences in metabolic response to continuous subcutaneous insulin infusion in pre-pubertal and pubertal children with Type 1 diabetes mellitus. J Endocrinol Invest. 2007;30:4774-4783
24. Pankowska E, Szypowska A, Lipka M. Basal insulin and total daily insulin dose in children with type 1 diabetes using insulin pumps. Pediatr Diabetes. 2008;9:208-213
25. Szadkowska A, Pietrzak I, Mianowska B, et al. Insulin sensitivity in Type 1 diabetic children and adolescents. Diabet Med. 2008;25:282-288
26. Ahmed ML, Ong KK, Watts AP, Morrell DJ, Preece MA, Dunger DB. Elevated leptin levels are associated with excess gains in fat mass in girls, but not boys, with type 1 diabetes: longitudinal study during adolescence. J Clin Endocrinol Metab. 2001;86:1188-1193
27. Caprio S, Cline G, Boulware S, et al. Effects of puberty and diabetes on metabolism of insulin-sensitive fuels. Am J Physiol. 1994;266:E885-E891
28. Edge JA, Dunger DB, Matthews DR, Gilbert JP, Smith CP. Increased overnight growth hormone concentrations in diabetic compared with normal adolescents. J Clin Endocrinol Metab. 1990;71:1356-1362
29. Edge JA, Matthews DR, Dunger DB. The dawn phenomenon is related to overnight growth hormone release in adolescent diabetics. Clin Endocrinol (Oxf). 1990;33:729-737
30. Clayton KL, Holly JMP, Carlsson LMS, et al. Loss of the normal relationship between growth hormone, growth hormone binding protein and insulin like growth factor in adolescents with insulin dependent diabetes mellitus. Clin Endocrinol (Oxf). 1994;41:517-524
31. Ekström K, Salemyr J, Zachrisson I, Carlsson-Skwirut C, Ortqvist E, Bang P. Normalization of the IGF-IGFBP axis by sustained nightly insulinization in type 1 diabetes. Diabetes Care. 2007;30:1357-1363
32. Perriello G, De Feo P, Torlone E, et al. The dawn phenomenon in type 1 diabetes mellitus: magnitude, frequency, variability, and dependency on glucose counterregulation and insulin sensitivity. Diabetologia. 1991;34:21-28
33. Szypowska A, Lipka M, Bfazik M, Golicka D, Groele L, Pańkowska E. Age-dependent basal insulin patterns in children with type 1 diabetes treated with continuous subcutaneous insulin infusion. Acta Paediatr. 2009;98:523-526
34. Holterhus PM, Odendahl R, Oesingmann S, et al; German/Austrian DPV Initiative; German Pediatric CSII Working Group. Classification of distinct baseline insulin infusion patterns in children and adolescents with type 1 diabetes on continuous subcutaneous insulin infusion therapy. Diabetes Care. 2007;30:568-573
35. Scheiner G, Boyer BA. Characteristics of basal insulin requirements by age and gender in Type-1 diabetes patients using insulin pump therapy. Diabetes Res Clin Pract. 2005;69:14-21
36. Klinkert C, Bachran R, Heidtmann B, Grabert M, Holl RW. Age-specific characteristics of the basal insulin-rate for pediatric patients on CSII. Exp Clin Endocrinol Diabetes. 2008;116:118-122
37. Rabbone I, Bobbio A, Berger K, Trada M, Sacchetti C, Cerutti F. Age-related differences in metabolic response to continuous subcutaneous insulin infusion in pre-pubertal and pubertal children with Type 1 diabetes mellitus. J Endocrinol Invest. 2007;30:477-483
38. Rohrer T, Stierkorb E, Heger S, et al; Diabetes-Patienten-Verlaufsdaten (DPV) Initiative. Delayed pubertal onset and development in German children and adolescents with type 1 diabetes: cross-sectional analysis of recent data from the DPV diabetes documentation and quality management system. Eur J Endocrinol. 2007;157:647-653
39. Du Caju MV, Rooman RP, op de Beeck L. Longitudinal data on growth and final height in diabetic children. Pediatr Res. 1995;38:607-611
40. Danielson KK, Palta M, Allen C, D'Alessio DJ. The association of increased total glycosylated hemoglobin levels with delayed age at menarche in young women with type 1 diabetes. J Clin Endocrinol Metab. 2005;90:6466-6471
41. Rohrer T, Stierkorb E, Grabert M, et al; DPV Initiative. Delayed menarche in young German women with type 1 diabetes mellitus: recent results from the DPV diabetes documentation and quality management system. Eur J Pediatr. 2008;167:793-799
42. Picardi A, Cipponeri E, Bizzarri C, Fallucca S, Guglielmi C, Pozzilli P. Menarche in type I diabetes is still delayed despite good metabolic control. Fertil Steril. 2008;90:1875-1877
43. Lombardo F, Salzano G, Crisafulli G, et al. Menarcheal timing in intensively treated girls with type 1 diabetes mellitus. Nutr Metab Cardiovasc Dis. 2009;19:35-38
44. Strotmeyer ES, Steenkiste AR, Foley TP Jr, Berga SL, Dorman JS. Menstrual cycle differences between women with type 1 diabetes and women without diabetes. Diabetes Care. 2003;26:1016-1021
45. Elamin A, Hussein O, Tuvemo T. Growth, puberty, and final height in children with Type 1 diabetes. J Diabetes Complications. 2006;20:252-256
46. Codner E, Cassorla F. Puberty and ovarian function in girls with type 1 diabetes mellitus. Horm Res. 2009;71:12-21
47. Kjaer K, Hagen C, Sando SH, Eshoj O. Epidemiology of menarche and menstrual disturbances in an unselected group of women with insulin-dependent diabetes mellitus compared to controls. J Clin Endocrinol Metab. 1992;75:524-529
48. Yeshaya A, Orvieto R, Dicker D, Karp M, Ben-Rafael Z. Menstrual characteristics of women suffering from insulin-dependent diabetes mellitus. Int J Fertil Menopausal Stud. 1995;40:269-273
49. Temple MY, Bar-Or O, Riddell MC. The reliability and repeatability of the blood glucose response to prolonged exercise in adolescent boys with IDDM. Diabetes Care. 1995;18:326-332
50. Bar-Or O. New and old in pediatric exercise physiology. Int J Sports Med. 2000;21(Suppl 2):S113-S117
51. Robertson K, Adolfsson P, Riddell M, Scheiner G, Hanas R. Exercise in children and adolescents with diabetes. Pediatric Diabetes. 2009;10(Suppl 12):S154-S168
52. Wysocki T, Taylor A, Hough BS, Linscheid TR, Yeates KO, Naglieri JA. Deviation from developmentally appropriate self-care autonomy. Associadon with diabetes outcomes. Diabetes Care. 1996;19:119-125
53. Blanz B, Rensch-Riemann B, Fritz-Sigmund D, Schmidt M. IDDM is a risk factor for adolescent psychiatric disorders. Diabetes Care. 1993;16:1579-1587
54. Kovacs M, Goldston D, Obrosky D, Bonar L. Psychiatric disorders in youths with IDDM: rates and risk factors. Diabetes Care. 1997;20:36-44
55. Grey M, Cameron M, Lipman TH, Thurber FW. Psychosocial status of children with diabetes in the first 2 years after diagnosis. Diabetes Care. 1995;18:1330-1336
56. Northam EA, Matthews LK, Anderson PJ, Cameron FJ, Werther GA. Psychiatric morbidity and health outcome in Type 1 diabetes-perspectives from a prospective longitudinal study. Diabet Med. 2005;22:152-157
57. Kovacs M, Iyengar S, Mukerji P, Drash A. Psychiatric disorder and metabolic control among youths with IDDM. Diabetes Care. 1996;19:318-323
58. Kovacs M, Goldston D, Obrosky S, Iyengar S. Prevalence and predictors of pervasive noncompliance with medical treatment among youths with insulin-dependent diabetes mellitus. J Am Acad Child Adolesc Psychiatry. 1992;31:1112-1119
59. Liss DS, Waller DA, Kenard BD, Mclntire D, Capra P, Stepherns J. Psychiatric illness and family support in children and adolescents with diabetic ketoacidosis: a controlled study. J Am Acad Child Adolesc Psychiatry. 1998;37:536-544
60. Cameron FJ, Northam EA, Ambler GR, Daneman D. Routine psychological screening in youth with type 1 diabetes and their parents: a notion whose time has come? Diabetes Care. 2007;30:2716-2724
61. American Diabetes Association. Standards of Medical Care in Diabetes. Diabetes Care. 2009;32:S13-S61
62. Delamater AM. Psychological care of children and adolescents with diabetes. Pediatric Diabetes. 2009;10(Suppl 12):175-184
63. de Wit M, Pouwer F, Gemke RJ, Delemarre-van de Waal HA, Snoek FJ. Validation of the WHO-5 Well-Being Index in adolescents with type 1 diabetes. Diabetes Care. 2007;30:2003-2006
64. Anderson BJ, Auslander WF, Jung KC, Miller JP, Santiago JV. Assessing family sharing of diabetes responsibilities. J Pediatr Psychol. 1990;15:477-492
65. Bums KL, Green P, Chase HP. Psychosocial correlates of glycemic control as a function of age in youth with IDDM. J Adolesc Health. 1986;7:311-319
66. Weissberg-Benchell J, Glasgow AM, Tynan WD, Wirtz P, Turek J, Ward J. Adolescent diabetes management and mismanagement. Diabetes Care. 1995;18:77-82
67. McBroom LA, Enriquez M. Review of family-centered interventions to enhance the health outcomes of children with type 1 diabetes. Diabetes Educ. 2009;35:428-438
68. Hampson SE, Skinner TC, Hart J, et al. Effects of educational and psychosocial interventions for adolescents with diabetes mellitus: a systematic review. Health Technol Assess. 2001;5:1-79
69. Armour TA, Norris SL, Jack L Jr, Zhang X, Fisher L. The effectiveness of family interventions in people with diabetes mellitus: a systematic review. Diabet Med. 2005;22:1295-1305
70. Dashiff C, Hardeman T, McLain R. Parent-adolescent communication and diabetes: an integrative review. J Adv Nurs. 2008;62:140-162
71. van Dam HA, van der Horst FG, Knoops L, Ryckman RM, Crebolder HF, van den Borne BH. Social support in diabetes: a systematic review of controlled intervention studies. Patient Educ Courts. 2005;59:1-12
72. Murphy HR, Rayman G, Skinner TC. Psycho-educational interventions for children and young people with Type 1 diabetes. Diabet Med. 2006;23:935-943
73. Hunter HL, Rosnov DL, Koontz D, Roberts M. Camping programs for children with chronic illness as a modality for recreation, treatment, and evaluation: an example of a mission-based program evaluation of a diabetes camp. J Clin Psychol Med Settings. 2006;13:67-80
74. Harkavy J, Johnson SB, Silverstein J, Spillar R, McCallum M, Rosenbloom A. Who leams what at diabetes summer camp. J Pediatr Psychol. 1983;8:143-153
75. Maslow GR, Lobato D. Diabetes summer camps: history, safety, and outcomes. Pediatric Diabetes. 2009;10:278-288
76. Rosen D. Between two worlds: Bridging the cultures of child health and adult medicine. J Adolesc Health. 1995;17:10-16
77. Callahan ST, Winitzer RF, Keenan P. Transition from pediatric to adult-oriented health care: a challenge for patients with chronic disease. Curr Opin Pediatr. 2001;13:310-316
78. Busse FP, Kapellen TM, Hiermann P, et al. Barriers of transfer of adolescents with diabetes mellitus type 1 into adulthood. Kinder-Jugendmed. 2003;3:188-192
79. Kipps S, Bahu T, Ong K, et al. Current methods of transfer of young people with type 1 diabetes to adult services. Diabet Med. 2002;19:649-654
80. McGill M. How do we organize smooth, effective transition from paediatric to adult diabetes care? Horn Res. 2002;57(Suppl 1):66-68
81. Blum RW, Garell D, Hadgman CH, et al. Transition from child-centred to adult health-care systems for adolescents with chronic conditions. A position paper of the Society for Adolescent Medicine. J Adol Health. 1993;14:570-576
82. Scal P, Ireland M. Addressing transition to adult health care for adolescents with special health care needs. Pediatrics. 2005;115:1607-1612
83. Cadario F, Prodam F, Bellone S, et al. Transition process of patients with type 1 diabetes (T1DM) from paediatric to the adult health care service: a hospital-based approach. Clin Endocrinol (Oxf. 2009;71:346-350
84. United Kingdom Department of Health. Transition: getting it right for young people: Improving the transition of young people with long term conditions from children's to adult health services 2007. Available at http://www.dh.gov. uk/en/PublicationsAndStatistics/Pubhcations/PublicationsPolicyAndGuidance/ DH-4132145. Accessed February 3, 2010
85. Kinmonth AL, Donovan C. The approach of general practice. In Kurtz Z, Hopkins A, eds. Services for Young People with Chronic Disorders in Their Transition from Childhood to Adult Life. London: Royal College of Physicians of London, 1996
86. Vanelli M, Caronna S, Adinolfi B, Chiari G, Gugliotta M, Arsenio L. Effectiveness of an uninterrupted procedure to transfer adolescents with Type 1 diabetes from the Paediatric to the Adult Clinic held in the same hospital: eight-year experience with the Parma protocol. Diabetes Nutr Metab. 2004;17:304-308
87. Holmes-Walker DJ, Llewellyn AC, Farrell K. A transition care programme which improves diabetes control and reduces hospital admission rates in young adults with Type 1 diabetes aged 15-25 years. Diabet Med. 2007;24:764-769
88. Barker JM. Clinical review: Type 1 diabetes-associated autoimmunity: natural history, genetic associations, and screening. J Clin Endocrinol Metab. 2006;91:1210-1217
89. De Block CE, De Leeuw IH, Vertommen JJ, et al; Belgian Diabetes Registry. Beta-cell, thyroid, gastric, adrenal and coeliac autoimmunity and HLA-DQ types in type 1 diabetes. Clin Exp Immunol. 2001;126:236-241
90. Roldan MB, Alonso M, Barrio R. Thyroid autoimmunity in children and adolescents with type 1 diabetes mellitus. Diabetes Nutr Metab. 1999;12:27-31
91. Kordonouri O, Deiss D, Danne T, Dorow A, Bassir C, Gruters-Kieslich A. Predictivity of thyroid autoantibodies for the development of thyroid disorders in children and adolescents with type 1 diabetes. Diabet Med. 2002;19:518-521
92. Kordonouri O, Klinghammer A, Lang EB, Grüters-Kieslich A, Grabert M, Holl RW. Thyroid autoimmunity in children and adolescents with type 1 diabetes: a multicenter survey. Diabetes Care. 2002;25:1346-1350
93. Kordonouri O, Hartmann R, Deiss D, Wilms M, Grüters-Kieslich A. Natural course of autoimmune thyroiditis in type 1 diabetes: association with gender, age, diabetes duration, and puberty. Arch Dis Child. 2005;90:411-414
94. American Diabetes Association. Standards of Medical Care in Diabetes-2009. Diabetes Care. 2009;32(Suppl 1):S13-S61
95. Kordonouri O, Maguire AM, Knip M, et al. Other complications and conditions associated with diabetes in children and adolescents. Pediatric Diabetes. 2009;10(Suppl 12):204-210
96. Collin P, Kaukinen K, Valimaki M, Salmi J. Endocrinological disorders and celiac disease. Endocr Rev. 2002;23:464-483
97. Tesei N, Sugai E, Vazquez H, et al. Antibodies to human recombinant tissue transglutaminase may detect celiac disease patients undiagnosed by endomysial antibodies. Alimen Pharm Ther. 2003;7:1415-1423
98. Cerutti F, Bruno G, Chiarelli F, Lorini R, Meschi F, Sacchetti C; Diabetes Study Group of the Italian Society of Pediatric Endocrinology and Diabetology. Younger age at onset and sex predict celiac disease in children and adolescents with type 1 diabetes: an Italian multicenter study. Diabetes Care. 2004;27:1294-1298
99. Larsson K, Carlsson A, Cederwall E, et al; Skane Study Group. Annual screening detects celiac disease in children with type 1 diabetes. Pediatric Diabetes. 2008;9:354-359
100. Holmes GK. Screening for coeliac disease in type 1 diabetes. Arch Dis Child. 2002;87:495-498
101. Barera G, Bonfanti R, Viscardi M, et al. Occurrence of celiac disease after onset of type 1 diabetes: a 6-year prospective longitudinal study. Pediatrics. 2002;109:833-838
102. Saukkonen T, Savilahti E, Reijonen H, et al. Coeliac disease: frequent occurrence after clinical onset of insulin dependent childhood diabetes in Finland Study Group. Diabet Med. 1996;13:464-470
103. Roldan MB, Barrio R, Roy G, et al. Diagnostic value of serological markers for celiac disease in diabetic children and adolescents. J Pediatr Endocrinol Metab. 1998;11:751-756
104. Westman E, Ambler GR, Royle M, et al. Children with coeliac disease and insulin dependent diabetes mellitus-growth, diabetes control and dietary intake. J Pediatr Endocrinol Metab. 1999;12:433-442
105. Mohn A, Cerruto M, Lafusco D, et al. Celiac disease in children and adolescents with type I diabetes: importance of hypoglycemia. J Ped Gastroent Nutr. 2001;32:37-40
106. Barker JM, Liu E. Celiac disease: pathophysiology, clinical manifestations, and associated autoimmune conditions. Adv Pediatr. 2008;55:349-365
107. Cataldo F, Marino V, Bottaro G, Greco P, Ventura A. Celiac disease and selective immunoglobulin A deficiency. J Pediatr. 1997;131:306-308
108. Lenhardt A, Plebani A, Marchetti F, et al. Role of human-tissue transglutaminase IgG and anti-gliadin IgG antibodies in the diagnosis of celiac disease in patients with selective immunoglobulin A deficiency. Dig Liver Dis. 2004;36:730-734
109. Anderson RP. Coeliac disease: current approach and future prospects. Intern Med J. 2008;38:790-799
110. Setty M, Hormaza L, Guandalini S. Celiac disease: risk assessment, diagnosis, and monitoring. Mol Diagn Ther. 2008;12:289-298
111. Farré C, Humbert P, Vilar P, et al. Serological markers and HLA-DQ2 haplotype among first-degree relatives of celiac patients. Catalonian Coeliac Disease Study Group. Dig Dis Sci. 1999;44:2344-2349
112. Karell K, Louka AS, Moodie SJ, et al. European Genetics Cluster on Celiac Disease. HLA types in celiac disease patients not carrying the DQA1*05-DQB17z.ast;02 (DQ2) heterodimer: results from the European Genetics Cluster on Celiac Disease. Hum Immunol. 2003;64:469-477
113. Lavant EH, Carlson JA. A new automated human leukocyte antigen genotyping strategy to identify DR-DQ risk alleles for celiac disease and type 1 diabetes mellitus. Clin Chem Lab Med. 2009;47:1489-1495
114. De Block CE, De Leeuw IH, Van Gaal LF. Autoimmune gastritis in type 1 diabetes: A clinically oriented review. J Clin Endocrinol Metab. 2008;93:363-371
115. Karavanaki K, Kakleas K, Paschali E, et al. Screening for associated autoimmunity in children and adolescents with type 1 diabetes mellitus (T1DM). Horm Res. 2009;71:201-206
116. De Block CE, De Leeuw IH, Rooman RP, Winnock F, Du Caju MV, Van Gaal LF. Gastric parietal cell antibodies are associated with glutamic acid decarboxylase-65 antibodies and the HLA DQA1*0501-DQB1*0301 haplotype in Type 1 diabetes mellitus. Belgian Diabetes Registry. Diabet Med. 2000;17:618-622
117. Kakkola A, Sjöblom SM, Haapiainen R, Sipponen P, Puolakkainen P, Jarvinen H. The risk of gastric carcinoma and carcinoid tumours in patients with pernicious anemia: a prospective follow-up study. Scand J Gastroenterol. 1998;33:88-92
118. Jarvisalo MI, Jartti L, Nanto-Salonen K, et al. Increased aortic intima-media thickness: a marker of preclinical adierosclerosis in high-risk children. Circulation. 2001;1:2943-2947
119. Dahl-Jorgensen K, Larsen JR, Hanssen KF. Atherosclerosis in childhood and adolescent type 1 diabee: early disease, early treatment? Diabetologia. 2005;48:1445-1453
120. Kavey RW, Allada V, Daniels SR, et al. Cardiovascular risk reduction in high-risk pediatric patients: a scientific statement from the American Heart Association Expert Panel on Population and Prevention Science; the Councils on Cardiovascular Disease in the Young, Epidemiology and Prevention, Nutrition, Physical Activity and Metabolism, High Blood Pressure Research, Cardiovascular Nursing, and the Kidney in Heart Disease; and the Interdisciplinary Working Group on Quality of Care and Outcomes Research: Endorsed by the American Academy of Pediatrics. Circulation. 2006;114:2710-2738
121. Practice guidelines and recommendations from the U. S. Preventive Services Task Force (USPSTF). Screening for lipid disorders in children. Pediatrics. 2007;120:e215-e219
122. Polak M, Souchon P-F, Benali K, Tubiana-Rufi N, Czernichow P. Type 1 diabetic children have abnormal lipid profiles during pubertal years. Pediatr Diabetes. 2000;1:74-81
123. Verrotti A, Chiarelli F, Morgese G. Influence of puberty on lipids and lipoprotein profile in children with type 1 diabetes mellitus. Acta Diabetol. 1995;32:102-105